Aprogen Biologics Inc.
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
003060 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003060001
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 송파구 백제고분로 480 4층 (방이동, 풍문빌딩), 서울특별시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Aprogen Biologics Inc. is a biopharmaceutical company specializing in the research, development, and manufacturing of advanced biologic medicines. Founded in 2000, the company leverages proprietary technologies in antibody and recombinant protein engineering to create a pipeline of both novel drugs and biosimilars. Its portfolio is focused on developing biosimilar products for various major biologics, including infliximab, trastuzumab, and rituximab, alongside a range of novel drug candidates. The company aims to provide innovative and accessible medicines for the professional medication market.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-29 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 100.6 KB | ||
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 5.0 MB | ||
| 2025-08-01 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 102.1 KB | ||
| 2025-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 639.1 KB | ||
| 2025-05-26 00:00 |
Share Issue/Capital Change
[기재정정]주요사항보고서(전환사채권발행결정)
|
Korean | 67.8 KB | ||
| 2025-05-26 00:00 |
M&A Activity
타법인주식및출자증권취득결정
|
Korean | 17.7 KB | ||
| 2025-05-22 00:00 |
Related Party Transaction
타법인주식및출자증권처분결정
|
Korean | 16.0 KB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 3.2 MB | ||
| 2025-05-07 00:00 |
Related Party Transaction
[기재정정]임원ㆍ주요주주특정증권등거래계획보고서
|
Korean | 73.8 KB | ||
| 2025-05-07 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 103.2 KB | ||
| 2025-05-07 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.4 KB | ||
| 2025-04-25 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 94.2 KB | ||
| 2025-04-25 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.5 KB | ||
| 2025-04-25 00:00 |
Capital/Financing Update
주권관련사채권의처분결정
|
Korean | 16.4 KB | ||
| 2025-04-11 00:00 |
Capital/Financing Update
타인에대한담보제공결정
|
Korean | 15.7 KB |
Automate Your Workflow. Get a real-time feed of all Aprogen Biologics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Aprogen Biologics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Aprogen Biologics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
